Apixaban in Venous Thromboembolism in an Era of New Oral Anticoagulants

E-ISSN： 2212-4063|15|2|139-147

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.15, Iss.2, 2015-08, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of New Oral Anticoagulants in the Treatment of Venous Thromboembolism and Thrombotic Prophylaxis

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 92-96

Bentham Science Publishers

Access to resources Recommend Favorite

New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 3, 2015-12 ,pp. : 204-209

Bentham Science Publishers

Access to resources Recommend Favorite

Rationale for Development of New Oral Anticoagulants

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 89-91

Bentham Science Publishers

Access to resources Recommend Favorite

New Oral Anticoagulants in Coronary Artery Disease

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 101-105

Bentham Science Publishers

Access to resources Recommend Favorite

The new oral anticoagulants: clinical use and reversal agent development

ISBT SCIENCE SERIES, Vol. 10, Iss. S1, 2015-04 ,pp. : 324-331

John Wiley & Sons Inc

Access to resources Recommend Favorite